back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-08-14 14:50 Tx date 2024-08-14 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,828
+1,200 vol $3.19 each |
8,000 | |
| Filed 2024-08-14 14:49 Tx date 2024-08-13 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,932
+2,800 vol $3.19 each |
6,800 | |
| Filed 2024-05-15 11:23 Tx date 2024-05-13 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$394,000
+100,000 vol $3.94 each |
100,000 | |
| Filed 2024-05-15 11:22 Tx date 2023-06-21 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-25 13:50 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$106,842
+26,187 vol $4.08 each |
26,187 | |
| Filed 2024-03-25 13:50 Tx date 2023-06-21 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-29 14:51 Tx date 2023-08-25 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,000
+4,000 vol $4.50 each |
4,000 | |
| Filed 2023-08-29 14:49 Tx date 2023-06-21 |
$HLS
HLS Therapeutics Inc. |
Hanna, John Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-26 23:23 Tx date 2019-10-22 |
$VCM
Vecima Networks Inc. |
Hanna, John Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,000
-4,000 vol $9.50 each |
3,847 | |
| Filed 2019-10-26 23:20 Tx date 2019-10-22 |
$VCM
Vecima Networks Inc. |
Hanna, John Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$34,480
+4,000 vol $8.62 each |
7,847 | |
| Filed 2015-12-19 Tx date 2015-12-15 |
$VCM
Vecima Networks Inc. |
Hanna, John Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Options Incentive Stock Options
51 - Exercise of options
|
$-5,156.58
-1,202 vol $4.29 each |
45,000 | |
| Filed 2015-12-19 Tx date 2015-12-15 |
$VCM
Vecima Networks Inc. |
Hanna, John Gordon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,156
+1,202 vol $4.29 each |
3,847 |